SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-12-063565
Filing Date
2012-02-15
Accepted
2012-02-15 17:06:37
Documents
4
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d288363d10qa.htm 10-Q/A 31017
2 MODIFICATION NO. P00005 TO CONTRACT NUMBER W9113M-10-C-0056 d288363dex103.htm EX-10.3 1058573
3 CERTIFICATION OF THE COMPANY'S PRESIDENT AND CHIEF EXECUTIVE OFFICER d288363dex311.htm EX-31.1 3070
4 CERTIFICATION OF THE COMPANY'S VICE PRESIDENT, FINANCE d288363dex312.htm EX-31.2 2995
  Complete submission text file 0001193125-12-063565.txt   1096770
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-14895 | Film No.: 12616706
SIC: 2834 Pharmaceutical Preparations